Clinical role for a superantigen in Yersinia pseudotuberculosis infection. - Wikidata - awgldk - TriplyDB

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

http://www.wikidata.org/entity/Q37365815

about

Kidney and urinary tract involvement in kawasaki disease Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.High affinity of interaction between superantigen and T cell receptor Vbeta molecules induces a high level and prolonged expansion of superantigen-reactive CD4+ T cells Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen Imaging of thrombi and assessment of left atrial appendage function: a prospective study comparing transthoracic and transoesophageal echocardiography.Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.Yersinia pseudotuberculosis septicemia and HIV.Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.Visceral lesions caused by Yersinia pseudotuberculosis, serotype II, in different species of bird.Kawasaki Disease Presenting with Bloody Diarrhea and Acute Renal Failure: First Case.A Child With Kawasaki Disease and Yersinia enterocolitica Infection: A Closer Look at Pathogenesis.Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum.Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen.Characterization and distribution of a new enterotoxin-related superantigen produced by Staphylococcus aureus.Far East Scarlet-like Fever Masquerading as Adult-onset Kawasaki Disease.Acute encephalopathy and tubulointerstitial nephritis associated with Yersinia pseudotuberculosis.

P2860

Q27009431-C4D8F438-B21A-4C54-B94A-64664FD85840 Q34004180-2EDE06B0-09B8-4870-942F-59C1D9884481 Q34155233-97FCCFAD-2679-4A8D-8AB6-D96A90DA794C Q34259452-D09310CE-7653-45EB-93EE-16176F815FA2 Q35370759-ABF7C44C-00FC-448D-82C0-BC7A976B661D Q35439554-B6990D16-9CCB-4C7E-A5E8-DEAA5F1038C6 Q35839567-D361C4EE-CA31-4A71-BC57-F701F698005C Q36022014-1BDAEC87-1E14-4E64-9762-3E0A9983B03D Q36305384-8C6BDEE0-245D-4369-B675-03485E05E66B Q38467754-2D26D52D-EBBA-4F67-9D27-E2B30F34FCC1 Q40980799-A32633C7-2E68-493B-8ADC-8B9DE268905E Q41380014-B21FB63A-BECF-43D5-92B4-E546FAF64A99 Q41453328-FB5C053A-311A-4E49-9821-30FC50984BE0 Q41487743-F0D3A35B-A66C-4B90-B49C-EEA4C479A1D0 Q47862557-0C225745-6DC5-4C73-ABFA-149AE4722F3F Q50221315-212FF9E8-0F13-42FD-834C-4204BAEDBBEE Q53126639-F340BC57-4E40-4CAB-BF6A-24FE10A7EA4C

P2860

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

http://www.wikidata.org/entity/Q37365815

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 1997

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@en

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@nl

type

label

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@en

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@nl

prefLabel

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@en

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@nl

P1433

Q37365815-1EA0437B-8741-4649-96B2-9464A60FEB4A

P1476

Q37365815-4BAF2B8C-8AEE-498F-A59D-945A8E9BDD83

P2093

Q37365815-51E94D73-F70D-4711-8056-037015491B8B

Q37365815-63782B63-DF57-4EA8-B36E-8FD5A44E3165

Q37365815-9CAF2102-CBF1-44BE-AFBD-ADA078620A3A

Q37365815-9D1D8B56-9B9C-4C9B-BBF1-1A1029071277

Q37365815-C695D606-4067-4B09-8445-59C3D39390E9

Q37365815-CC3EA555-728D-41F2-BE64-317DE25604A8

Q37365815-CD5F32B5-D8DB-4FD9-8FA1-869C79172855

Q37365815-FEA31FD4-77EC-418B-AC4E-3CE4C4EB69E5

P2860

Q37365815-0029B987-400A-42F0-ADED-2F2311DA0698

Q37365815-029D2C86-6CD9-4343-90AD-C5FBA1E6F37F

Q37365815-0624F927-D79E-469A-9D9A-771A8CCD574A

Q37365815-0B0A71ED-02DD-469C-9DE6-6B460E0945E0

Q37365815-18BFECB7-95CF-44E5-AD7C-FB2DF4496F36

Q37365815-1907279C-138C-4B25-91F1-DD2E3F30CC6D

Q37365815-1964560C-FB79-43FC-BC7B-1359D1D2A30A

Q37365815-19FA157C-57CE-4A40-B9AD-DBF69F751916

Q37365815-1F32AE11-2CEF-4E63-B99B-BADBDCAA9D32

Q37365815-229407D0-E66B-424C-B36A-20037D2A0014

P304

Q37365815-536308D6-4FDD-40CC-8682-9E851D21CDED

P31

Q37365815-C5C4A46B-FAAC-4F87-AA02-FCFC3868DDC7

P356

Q37365815-78D5DFBA-33DA-4CBE-B6BF-67840D3A912C

P407

Q37365815-5F89555C-FFC6-422B-9327-BBF399EB99AA

P433

Q37365815-3F00E5D1-E37E-4192-B1F7-92F9064D2588

P478

Q37365815-CB500303-3516-41BD-B66C-C22429E9521A

P577

Q37365815-FD444A46-4C2E-44DC-BD66-B53F65F3D092

P698

Q37365815-D5F96B37-AC87-48E8-BF9A-BC50A9CA7C68

P921

Q37365815-F63B0E04-41A6-4A11-8C9E-E8A85D6458BE

P932

Q37365815-E5948830-8E6E-4420-BEE7-7C4372BC6E3F

P356

P1433

Journal of Clinical Investigation

P1476

Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

@en

P2093

Abe J

http://www.w3.org/2001/XMLSchema#string

Baba K

http://www.w3.org/2001/XMLSchema#string

Ito Y

http://www.w3.org/2001/XMLSchema#string

Kohsaka T

http://www.w3.org/2001/XMLSchema#string

Matsumoto S

http://www.w3.org/2001/XMLSchema#string

Noma S

http://www.w3.org/2001/XMLSchema#string

Onimaru M

http://www.w3.org/2001/XMLSchema#string

Takeda T

http://www.w3.org/2001/XMLSchema#string

P2860

Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms

Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains

Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B.

The human T cell receptor beta-chain gene complex contains at least 57 variable gene segments. Identification of six V beta genes in four new gene families.

Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response.

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.

The staphylococcal enterotoxins and their relatives.

P304

1823-1830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI119349

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9109426

http://www.w3.org/2001/XMLSchema#string

P921

Yersinia pseudotuberculosis

P932

508006

http://www.w3.org/2001/XMLSchema#string